| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |